Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Cardiovascular effects of lactate in healthy adults

Fig. 1

Study design. A randomized, double-blind, controlled cross-over trial in eight participants investigated at two study visits separated by ≥ 14 days washout period. At the first visit, participants were randomized to receive an intravenous infusion of either weight-adjusted half-molar sodium lactate (LAC) infusion or hypertonic sodium chloride (SAL). At the second visit, participants received the opposite treatment compared with the first visit. Serial echocardiographic evaluation and blood samples were collected before the infusion and at 60, 120, and 240 min during infusion

Back to article page

Critical Care

ISSN: 1364-8535